Literature DB >> 30963614

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.

P V Chernyshov1, A Lallas2, L Tomas-Aragones3, M Arenbergerova4, M Samimi5, L Manolache6, A Svensson7, S E Marron8, F Sampogna9, S Spillekom-vanKoulil10, A Bewley11,12, A M Forsea13, G B Jemec14,15, J C Szepietowski16, M Augustin17, A Y Finlay18.   

Abstract

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer (NMSC) present a review of the literature and position statement on health-related (HR) QoL assessment in skin cancer patients. A literature search was carried out to identify publications since 1980 that included information about the impact of SC on QoL. Generic, dermatology-specific, cancer-specific, SC-specific, facial SC-specific, NMSC-specific, basal cell carcinoma-specific and melanoma-specific QoL questionnaires have been used to assess HRQoL in SC patients. HRQoL was assessed in the context of creation and validation of the HRQoL instruments, clinical trials, comparison of QoL in SC and other cancers, other diseases or controls, HRQoL assessment after treatment, comorbidities, behaviour modification, predictors of QoL and survival, supportive care needs, coping strategies and fear of cancer recurrence. The most widely used instruments for HRQoL assessment in SC patients are the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30), the Functional Assessment of Cancer Therapy-Melanoma (FACT-M), Skin Cancer Index (SCI), Short Form 36 Item Health Survey (SF-36) and the Dermatology Life Quality Index (DLQI). The TFs recommend the use of the cancer-specific EORTC QLQ-C30, especially in late stages of disease, and the melanoma-specific FACT-M and SC-specific SCI questionnaires. These instruments have been well validated and used in several studies. Other HRQoL instruments, also with good basic validation, are not currently recommended because the experience of their use is too limited. Dermatology-specific HRQoL instruments can be used to assess the impact of skin-related problems in SC. The TFs encourage further studies to validate HRQoL instruments for use in different stages of SC, in order to allow more detailed practical recommendations on HRQoL assessment in SC.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Year:  2019        PMID: 30963614     DOI: 10.1111/jdv.15487

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

1.  Advocacy for a shared physician/patient approach for the management of acne, rosacea, seborrheic dermatitis and photodamage.

Authors:  Brigitte Dréno; Richard L Gallo; Enzo Berardesca; Christopher E M Griffiths
Journal:  Eur J Dermatol       Date:  2022-01-01       Impact factor: 2.805

Review 2.  A structured review of quality of life in advanced and high-risk cutaneous squamous cell carcinoma shows the need for more studies and better measures.

Authors:  R Starkings; V Shilling; V Jenkins; L Fallowfield
Journal:  Skin Health Dis       Date:  2021-05-07

3.  Quality of Life During Treatment for Cervicofacial Non-melanoma Skin Cancer.

Authors:  Pablo García-Montero; María Victoria de Gálvez-Aranda; Nuria Blázquez-Sánchez; Francisco Rivas-Ruíz; José Francisco Millán-Cayetano; Cristina García-Harana; Magdalena de Troya Martín
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

4.  Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas.

Authors:  Francesca Sampogna; Andrea Paradisi; Maria Luisa Iemboli; Luca Fania; Francesco Ricci; Monica Napolitano; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2021-04-27       Impact factor: 3.875

5.  Quality of Life in Patients with Surgically Removed Skin Tumors.

Authors:  Laura Răducu; Adelaida Avino; Raluca Purnichescu Purtan; Andra-Elena Balcangiu-Stroescu; Daniela Gabriela Bălan; Delia Timofte; Dorin Ionescu; Cristian-Radu Jecan
Journal:  Medicina (Kaunas)       Date:  2020-02-09       Impact factor: 2.430

Review 6.  Quality of Life in Hidradenitis Suppurativa: An Update.

Authors:  Pavel V Chernyshov; Andrew Y Finlay; Lucia Tomas-Aragones; Francoise Poot; Francesca Sampogna; Servando E Marron; Sergey V Zemskov; Damiano Abeni; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

7.  Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic.

Authors:  P V Chernyshov; L Tomas-Aragones; M Augustin; A Svensson; A Bewley; F Poot; J C Szepietowski; S E Marron; L Manolache; N Pustisek; A Suru; C M Salavastru; C Blome; M S Salek; D Abeni; F Sampogna; F Dalgard; D Linder; A W M Evers; A Y Finlay
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-29       Impact factor: 9.228

8.  2-Methoxyestradiol and Its Combination with a Natural Compound, Ferulic Acid, Induces Melanoma Cell Death via Downregulation of Hsp60 and Hsp90.

Authors:  Anna Kamm; Paulina Przychodzeń; Alicja Kuban-Jankowska; Antonella Marino Gammazza; Francesco Cappello; Agnieszka Daca; Michał A Żmijewski; Michał Woźniak; Magdalena Górska-Ponikowska
Journal:  J Oncol       Date:  2019-10-02       Impact factor: 4.375

9.  Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.

Authors:  Yucang Shi; Zhanpeng Li; Zhihong Zhou; Simu Liao; Zhiyuan Wu; Jie Li; Jiasheng Yin; Meng Wang; Meilan Weng
Journal:  PeerJ       Date:  2022-01-21       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.